Minimal Change Disease: Clinical Trials

4 trials for Minimal Change Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 2, Completed 1, Not yet recruiting 1
Phase 22Completed 1, Unknown 1

Follow Minimal Change Disease: new trials by email Literature Review of Minimal Change Disease trials Research Report on Minimal Change Disease

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD
Supportive care+Prednisone, Supportive care+Tacrolimus+Ripertamab, Supportive care+Ripertamab - Minimal Change Disease
Phase 3Not yet recruitingAir Force Military Medical University, China812024-05-012024-05-08
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome
Rituximab, Prednisone - Idiopathic Nephrotic Syndrome, Minimal Change Disease
Phase 3UnknownRadboud University Medical Center402018-08-222018-08-27
Valproic Acid for Idiopathic Nephrotic Syndrome
Valproic Acid - Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis
Phase 2 / Phase 3UnknownUniversitair Ziekenhuis Brussel152016-10-012017-06-20
Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome
Tacrolimus - Minimal Change Disease
Phase 2 / Phase 3CompletedSeoul National University Hospital202010-06-012011-08-16

Narrower conditions

Nephrosis, Lipoid (4)  ·  Glomerulosclerosis, Focal Segmental (2)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Nephrosis (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Glomerulonephritis (2)  ·  Nephritis (2)

Interventions

Control Groups (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Rituximab (1)  ·  Tacrolimus (1)  ·  Valproic Acid (1)

Sponsors

Air Force Military Medical University, China (1)  ·  Radboud University Medical Center (1)  ·  Seoul National University Hospital (1)  ·  Universitair Ziekenhuis Brussel (1)

Countries

Belgium (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Jack F Wetzels, MD, PhD (1)  ·  Jeroen K Deegens, MD,PhD (1)  ·  Peter Janssens, MD (1)

Results publications

PMID 35224732, PMID 35230699